vs

Side-by-side financial comparison of Amalgamated Financial Corp. (AMAL) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($90.3M vs $85.2M, roughly 1.1× Amalgamated Financial Corp.). On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs 9.4%). Amalgamated Financial Corp. produced more free cash flow last quarter ($134.4M vs $11.3M). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs 4.3%).

CI Financial is a Canadian investment management company based in Toronto, Ontario. It offers investment management and wealth management services targeted to high net worth retail investors, as well as brokerage and trading services to portfolio managers and institutional investors.

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

AMAL vs EOLS — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.1× larger
EOLS
$90.3M
$85.2M
AMAL
Growing faster (revenue YoY)
EOLS
EOLS
+5.0% gap
EOLS
14.4%
9.4%
AMAL
More free cash flow
AMAL
AMAL
$123.1M more FCF
AMAL
$134.4M
$11.3M
EOLS
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
23.4%
4.3%
AMAL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMAL
AMAL
EOLS
EOLS
Revenue
$85.2M
$90.3M
Net Profit
$130.0K
Gross Margin
65.7%
Operating Margin
39.0%
4.7%
Net Margin
0.1%
Revenue YoY
9.4%
14.4%
Net Profit YoY
101.9%
EPS (diluted)
$0.88
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMAL
AMAL
EOLS
EOLS
Q4 25
$85.2M
$90.3M
Q3 25
$85.6M
$69.0M
Q2 25
$80.9M
$69.4M
Q1 25
$77.0M
$68.5M
Q4 24
$77.9M
$78.9M
Q3 24
$81.0M
$61.1M
Q2 24
$78.5M
$66.9M
Q1 24
$78.3M
$59.3M
Net Profit
AMAL
AMAL
EOLS
EOLS
Q4 25
$130.0K
Q3 25
$26.8M
$-15.7M
Q2 25
$26.0M
$-17.1M
Q1 25
$25.0M
$-18.9M
Q4 24
$-6.8M
Q3 24
$27.9M
$-19.2M
Q2 24
$26.8M
$-11.3M
Q1 24
$27.2M
$-13.1M
Gross Margin
AMAL
AMAL
EOLS
EOLS
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Q1 24
68.3%
Operating Margin
AMAL
AMAL
EOLS
EOLS
Q4 25
39.0%
4.7%
Q3 25
42.9%
-16.7%
Q2 25
43.8%
-14.7%
Q1 25
45.1%
-22.1%
Q4 24
42.4%
-2.9%
Q3 24
47.2%
-25.3%
Q2 24
45.6%
-11.5%
Q1 24
49.2%
-15.0%
Net Margin
AMAL
AMAL
EOLS
EOLS
Q4 25
0.1%
Q3 25
31.3%
-22.8%
Q2 25
32.1%
-24.7%
Q1 25
32.5%
-27.6%
Q4 24
-8.6%
Q3 24
34.5%
-31.4%
Q2 24
34.1%
-17.0%
Q1 24
34.8%
-22.1%
EPS (diluted)
AMAL
AMAL
EOLS
EOLS
Q4 25
$0.88
$0.01
Q3 25
$0.88
$-0.24
Q2 25
$0.84
$-0.27
Q1 25
$0.81
$-0.30
Q4 24
$0.78
$-0.11
Q3 24
$0.90
$-0.30
Q2 24
$0.87
$-0.18
Q1 24
$0.89
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMAL
AMAL
EOLS
EOLS
Cash + ST InvestmentsLiquidity on hand
$291.2M
$53.8M
Total DebtLower is stronger
$146.1M
Stockholders' EquityBook value
$794.5M
$-23.1M
Total Assets
$8.9B
$225.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMAL
AMAL
EOLS
EOLS
Q4 25
$291.2M
$53.8M
Q3 25
$115.5M
$43.5M
Q2 25
$171.1M
$61.7M
Q1 25
$65.7M
$67.9M
Q4 24
$60.7M
$87.0M
Q3 24
$149.2M
$85.0M
Q2 24
$58.0M
$93.7M
Q1 24
$155.2M
$97.0M
Total Debt
AMAL
AMAL
EOLS
EOLS
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Q1 24
$120.6M
Stockholders' Equity
AMAL
AMAL
EOLS
EOLS
Q4 25
$794.5M
$-23.1M
Q3 25
$775.6M
$-28.8M
Q2 25
$754.0M
$-18.7M
Q1 25
$736.0M
$-6.6M
Q4 24
$707.7M
$5.5M
Q3 24
$698.2M
$5.9M
Q2 24
$646.0M
$19.3M
Q1 24
$616.8M
$18.4M
Total Assets
AMAL
AMAL
EOLS
EOLS
Q4 25
$8.9B
$225.9M
Q3 25
$8.7B
$219.0M
Q2 25
$8.6B
$228.8M
Q1 25
$8.3B
$213.4M
Q4 24
$8.3B
$232.6M
Q3 24
$8.4B
$229.6M
Q2 24
$8.3B
$233.8M
Q1 24
$8.1B
$226.2M
Debt / Equity
AMAL
AMAL
EOLS
EOLS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×
Q1 24
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMAL
AMAL
EOLS
EOLS
Operating Cash FlowLast quarter
$135.8M
$12.8M
Free Cash FlowOCF − Capex
$134.4M
$11.3M
FCF MarginFCF / Revenue
157.8%
12.6%
Capex IntensityCapex / Revenue
1.6%
1.6%
Cash ConversionOCF / Net Profit
98.67×
TTM Free Cash FlowTrailing 4 quarters
$229.4M
$-45.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMAL
AMAL
EOLS
EOLS
Q4 25
$135.8M
$12.8M
Q3 25
$39.5M
$-14.7M
Q2 25
$24.9M
$-24.8M
Q1 25
$34.2M
$-15.6M
Q4 24
$124.1M
$4.8M
Q3 24
$35.8M
$-5.7M
Q2 24
$28.0M
$-6.5M
Q1 24
$31.3M
$-10.6M
Free Cash Flow
AMAL
AMAL
EOLS
EOLS
Q4 25
$134.4M
$11.3M
Q3 25
$38.3M
$-15.6M
Q2 25
$24.2M
$-25.5M
Q1 25
$32.5M
$-16.0M
Q4 24
$122.3M
$4.4M
Q3 24
$35.2M
$-6.0M
Q2 24
$27.8M
$-6.9M
Q1 24
$31.1M
$-10.9M
FCF Margin
AMAL
AMAL
EOLS
EOLS
Q4 25
157.8%
12.6%
Q3 25
44.7%
-22.7%
Q2 25
29.9%
-36.7%
Q1 25
42.2%
-23.3%
Q4 24
157.0%
5.5%
Q3 24
43.4%
-9.9%
Q2 24
35.4%
-10.4%
Q1 24
39.7%
-18.3%
Capex Intensity
AMAL
AMAL
EOLS
EOLS
Q4 25
1.6%
1.6%
Q3 25
1.4%
1.4%
Q2 25
0.9%
1.0%
Q1 25
2.3%
0.5%
Q4 24
2.3%
0.6%
Q3 24
0.7%
0.5%
Q2 24
0.3%
0.7%
Q1 24
0.3%
0.4%
Cash Conversion
AMAL
AMAL
EOLS
EOLS
Q4 25
98.67×
Q3 25
1.47×
Q2 25
0.96×
Q1 25
1.37×
Q4 24
Q3 24
1.28×
Q2 24
1.05×
Q1 24
1.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons